GCM
CAI icon

Ghisallo Capital Management’s Caris Life Sciences CAI Stock Holding History

Ghisallo Capital Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Sell
100,000
-150,000
-60% -$2.68M 0.04% 260
2026
Q1 		$4.47M Sell
250,000
-595,332
-70% -$13M 0.12% 132
2025
Q4 		$22.8M Sell
845,332
-202,831
-19% -$5.71M 1.02% 20
2025
Q3 		$31.7M Hold
1,048,163
– – 1.04% 21
2025
Q2 		$28M Buy
+1,048,163
New +$28.2M 0.75% 31

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Ghisallo Capital Management's CAI Position: Q2 2026 in Review

Ghisallo Capital Management reduced its Caris Life Sciences (CAI) stake by 60% in Q2 2026, selling an estimated $2.68M and leaving 100,000 shares worth $1.78M. The position accounts for 0.04% of the portfolio, ranked #260.

Ghisallo Capital Management first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $31.7M in Q3 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Ghisallo Capital Management held 100,000 shares of Caris Life Sciences worth $1.78M as of Q2 2026.
  • Ghisallo Capital Management sold 150,000 Caris Life Sciences shares in Q2 2026, an estimated $2.68M.
  • Caris Life Sciences made up 0.04% of Ghisallo Capital Management's portfolio in Q2 2026, its #260 holding.
  • Ghisallo Capital Management first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Ghisallo Capital Management's Caris Life Sciences position peaked at $31.7M in Q3 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.